Intrasaccular Embolization Systems Market: Global Industry Analysis 2014 -2018 and Opportunity Assessment; 2019 - 2029

Market Overview

An aneurysms is a condition which happens when there is thinning of the blood vessel wall either because of damage to blood vessels or an increased blood pressure, which can lead to intracranial bleeding. A bleeding can cause stroke, blood clots and increased intracranial pressure. Intrasaccular embolization systems usually involves restricting the blood flow in formed aneurysm. The intrasaccular embolization systems also constitutes surgical intervention to fill up the aneurysms, typically a devices known as embolic coil is inserted into the aneurysms and restriction of the blood platelets in the brain is achieved. The intrasaccular embolization systems facilitate rapid clotting and elimination of additional damage to the brain. The minimized risk of surgical intervention in adjacent part of the brain is achieved through the use of preventive stenting by intrasaccular embolization systems. Furthermore, the hemostasis is achieved with the help of endovascular repair. The time required in receiving intrasaccular embolization procedure plays a major role in survival of intracranial aneurysms patient. The intrasaccular embolization systems offers primal advantage in quick recovery of the patient.

The major driving factor for intrasaccular embolization systems market is increasing in incidences of brain aneurysms, reasoning to the increasing burden of chronic diseases. As per American brain aneurysm foundation, aneurysms accounts for approximately 10-12 percent of stroke cases. Wherein about 10% to 14% of people are affected with intracranial bleeding which leads to death. The rise in new incidences of venous diseases drives the intrasaccular embolization systems market. Furthermore, the increasing utilization of antihypertensive drugs also escalate the likelihoods for intracranial aneurysms subsequently increasing the demand for intrasaccular embolization systems. The major advantage of device based intrasaccular embolization systems is quick action and reduced recovery time which in case of Intrasaccular aneurysms results in wellbeing of the patient. The shorter onset of action of Coil or Web system is anticipated to boost the market for intrasaccular embolization systems. The increasing prescription rate of antihypertensive drugs by physicians and high clinical effectiveness of intrasaccular embolization systems is anticipated to expand the market for intrasaccular embolization systems. Increasing consumption of venous dilator coupled with increasing number of patients with high blood pressure is anticipated to increase the risk of aneurysms stroke, thereby it is anticipated to propel the market for intrasaccular embolization systems. However, rigid regulatory guidelines for devices used in intrasaccular embolization systems coupled with high cost of procedure is anticipated to restrain the growth of the intrasaccular embolization systems market.

The global Intrasaccular Embolization Systems market is anticipated to show exponential growth as it offers treatment and primary care for brain aneurysms. Due to growing demand of minimal invasive procedure for intracranial surgeries and disease conditions is anticipated to boost the demand for Intrasaccular Embolization Systems market. Specifically, therapeutic Intrasaccular Embolization Systems is anticipated to show significantly higher growth rate. In the upcoming years, the global Intrasaccular Embolization Systems market is anticipated to offer new entry strategy for new market players which is anticipated to increase market competition in the intrasaccular embolization systems market. And additionally higher consumption of the antihypertensive drugs and increased tension on the veins is also anticipated to effect the intrasaccular embolization systems market. Hence, with the rapidly growing geriatric population, additionally adult female and male population which are highly vulnerable to have a venous disease and disorder, thereby the market for Intrasaccular Embolization Systems is expected to increase at a fixed rate.

Geographically, the global Intrasaccular Embolization Systems market is segmented into regions viz. North America, Latin America, Europe, south Asia, East Asia, Oceania and the Middle East and Africa (MEA). North America is anticipated to be the dominant market in the global Intrasaccular Embolization Systems market owing to higher technological advancement and recent FDA approvals for WEB system. The Intrasaccular Embolization Systems market in the East Asia is projected to grow significantly reasoning to the growing product approvals and recent rise in healthcare standards in japan and china. Europe is anticipated to hold the second largest share in the global Intrasaccular Embolization Systems market throughout the study period owning to the increase in incidence of aneurysms.

The global market for Intrasaccular Embolization Systems is fragmented with large number of market players. Examples of some of the primary key players operating in the global Intrasaccular Embolization Systems market are

• MicroVention, Inc.
• Medtronic Plc.
• stryker
• Cook medical
• dePuySynthes
• Kaneka
• Penubbra
• Braile Biomedica.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers an exhaustive analysis on:

• Intrasaccular Embolization Systems Market Segments
• Intrasaccular Embolization Systems Market Dynamics
• Intrasaccular Embolization Systems Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico, Brazil, Argentina, Chile, Peru, rest of Latin America)
• Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe)
• East Asia
• South Asia
• Oceana
• Middle East and Africa (GCC, S. Africa, Turkey, Iran, Israel, Rest Of MEA)